SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-18-020312
Filing Date
2018-04-12
Accepted
2018-04-12 16:55:18
Documents
5
Effectiveness Date
2018-04-12

Document Format Files

Seq Description Document Type Size
1 DEFA14A tv490938_defa14a.htm DEFA14A 20334
2 GRAPHIC image_001.jpg GRAPHIC 289008
3 GRAPHIC image_002.jpg GRAPHIC 380471
4 GRAPHIC image_003.jpg GRAPHIC 144642
5 GRAPHIC image_004.jpg GRAPHIC 4150
  Complete submission text file 0001144204-18-020312.txt   1148973
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50626 | Film No.: 18752570
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1